Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 13/20 | 0.55 |
| ▸ | MAOA | P21397 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | CALML3 | P27482 | 1/20 | 0.51 |
| ▸ | SDHA | P31040 | 1/20 | 0.51 |
| ▸ | F10 | P00742 | 7/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5833346 | 0.89 | F10 (0.50) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL5834389 | 0.89 | F10 (0.50) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL6763432 | 0.89 | MAOB (0.49) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL6763433 | 0.89 | MAOB (0.49) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL21999243 | 0.89 | MAOB (0.57) | MAOBMAOALMNAPTGS1CALML3 | |
| Hydrochloric Acid SCHEMBL5834140 | 0.89 | F10 (0.49) | MAOBMAOALMNAPTGS1CALML3 | |
| Hydrochloric Acid SCHEMBL5833874 | 0.89 | F10 (0.49) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL5834130 | 0.86 | MAOB (0.39) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL5833205 | 0.86 | F10 (0.43) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL5833986 | 0.86 | F10 (0.46) | MAOBMAOALMNAPTGS1CALML3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6734200-B1 | ANTIBIOTIC COMPOUNDS CONTAINING A SUBSTITUTED OXAZOLIDINONE RING; ACTIVITY AGAINST GRAM-POSITIVE PATHOGENS | ASTRAZENECA AB (SE) | 2004-05-11 | — | — | US | disclosed |